Humanwell Healthcare (SHA:600079) unit obtained China's regulatory approval to begin clinical trials for RFUS-188 to treat acute pain, according to a Thursday filing with the Shanghai bourse.
The drug targets peripheral kappa opioid receptors without crossing the blood-brain barrier, potentially eliminating the addiction, respiratory depression and other severe side effects of traditional opioids
Shares of the pharmaceutical company declined 1% in recent trade.
Shares of Australia-listed uranium producers rose in recent Thursday trade as the New South Wales Uranium Bill was passed into law on Monday, according to a Thursday statement by the Minerals Council of Australia.Shares of Deep Yellow (ASX:DYL) rose 5%, while Paladin Energy (ASX:PDN) gained 7% and Nexgen Energy (ASX:NXG) added 6%.The new legislation removes the NSW prohibitions on uranium mining and nuclear energy, according to the statement.
Zeotech (ASX:ZEO) started a new air-core drilling program at the Toondoon project in Queensland, with 119 holes covering 3,500 meters, according to a Thursday filing with the Australian bourse.The program, designed to increase confidence in the project's mineral resource, will focus on infill grade control drilling on mining lease 80126 and step-out exploration targeting high-prospect areas across exploration permits 27395 and 27866, the filing said.
China's Ministry of Finance plans to issue 84 billion yuan in treasury bonds in Hong Kong this year, the ministry said in a Wednesday disclosure.The renminbi-denominated treasury bonds in Hong Kong for this year are higher than the 68 billion yuan issued a year earlier, Xinhua reported on the same day.The bonds for this year will be issued in six tranches, with the first two amounting to 29.5 billion yuan already issued in February and April, according to the ministry.